GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncovista Innovative Therapies OVIT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2014

Net income

−$2.5m

FY2014FY2014

Free cash flow

−$232,388

FY2014FY2014

Shareholders' equity

−$5.7m

FY2014FY2014

Income statement

Fiscal years

FY2014
Research and development$669,405
Operating income−$2.5m
Net income−$2.5m
Diluted earnings per share-0.02

Balance sheet

At each fiscal year end

FY2014
Total assets$12,514
Cash and short-term investments$12,514
Total liabilities$5.7m
Debt$208,329
Shareholders' equity−$5.7m
Shares outstanding125m

Cash flow

Fiscal years

FY2014
Cash from operations−$232,384
Capital spending−$4
Free cash flow−$232,388

Latest quarters

By quarter end

Sept 2015Jun 2015Mar 2015Dec 2014Sept 2014Jun 2014Mar 2014Sept 2013
Operating income−$317,397−$1.1m−$272,824−$1.7m−$286,754−$287,744−$245,343−$339,519
Net income−$326,098−$1.1m−$277,489−$1.6m$226,846−$892,926−$307,357−$368,666
Diluted earnings per share-0.01-0.05-0.01-0.010.00-0.01-0.00-0.02
Total assets$61,270$28,068$56,030$12,514$119,226$99,527$80,816$160,890
Cash and short-term investments$61,270$28,068$56,030—$75,631$55,932$29,871$75,189
Debt$479,298$410,597$322,995$208,329$204,267$101,667——
Shareholders' equity−$6.6m−$7.0m−$5.9m−$5.7m−$4.1m−$4.3m−$3.4m−$2.7m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income5.0%-8.3%19.7%
Net income7.9%-11.9%19.1%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return100%100%300%-87%-27%5755%1505%844%12494%-62%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1.474-for-1 split · 29 Oct 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.